formylmethionyl-leucyl-phenylalanine methyl ester has been researched along with gabexate in 1 studies
| Studies (formylmethionyl-leucyl-phenylalanine methyl ester) | Trials (formylmethionyl-leucyl-phenylalanine methyl ester) | Recent Studies (post-2010) (formylmethionyl-leucyl-phenylalanine methyl ester) | Studies (gabexate) | Trials (gabexate) | Recent Studies (post-2010) (gabexate) |
|---|---|---|---|---|---|
| 67 | 1 | 6 | 743 | 53 | 106 |
| Protein | Taxonomy | formylmethionyl-leucyl-phenylalanine methyl ester (IC50) | gabexate (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 0.9 | |
| Coagulation factor X | Homo sapiens (human) | 4.61 | |
| Plasminogen | Homo sapiens (human) | 0.431 | |
| Urokinase-type plasminogen activator | Homo sapiens (human) | 0.431 | |
| Serine protease hepsin | Homo sapiens (human) | 0.383 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kistler, EB; Mitsuoka, H; Schmid-Schönbein, GW | 1 |
1 other study(ies) available for formylmethionyl-leucyl-phenylalanine methyl ester and gabexate
| Article | Year |
|---|---|
Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock.
Topics: Animals; Blood Pressure; Endopeptidases; Esters; Gabexate; Guanidines; Humans; In Vitro Techniques; Inflammation; Intestinal Mucosa; Intestines; Leukocytes; Male; Multiple Organ Failure; N-Formylmethionine Leucyl-Phenylalanine; Neutropenia; Phospholipases A; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion; Serine Endopeptidases; Serine Proteinase Inhibitors; Shock; Splanchnic Circulation; Survival Rate | 2002 |